Gene change sheds light on sex development disorder

NewsGuard 100/100 Score

One in 4,500 people suffer from a group of conditions known as sex development disorders (DSD) which occur when the sex chromosomes do not match the genitalia.

DSD can result in defects in the sexual characteristics of a baby, where the gender at birth is not clearly male or female, or where the physical sex of the person does not match the sex of their chromosomes (i.e.. XY females and XX males).

In the majority of DSD cases the underlying genetic mutations are unknown.

Now Australian researchers have discovered how a change to one gene halts the process of an embryo becoming a boy and they believe their research could lead to improved genetic diagnoses, counseling and treatment options.

Some DSD children are born with ambiguous or incomplete genitalia, making it difficult to identify gender while others develop female genitalia despite being genetically male and are raised as girls.

The disorder which is usually only diagnosed at puberty, when girls do not begin to menstruate, renders many DSD sufferers infertile because their internal sex organs are not fully developed.

A team at Prince Henry's Institute (PHI) in Melbourne have discovered in the laboratory how an extra copy of a gene on the X chromosome stops testicles developing in babies who are genetically male.

The researchers found that when they increased the presence of the gene, called DAX1, in cells grown in a laboratory, the cells reduced production of a protein critical for testicle formation which in turn prevents the production of testosterone, which is necessary for the development of the penis.

The researchers say they hope their research will help parents and help experts offer the best treatment options, whether it be hormonal therapy or a surgical therapy.

The PHI researchers hope the discovery of the genes responsible for DSD disorders will allow them to map the 80 per cent of cases that remain unexplained genetically.


The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New modular epigenome editing platform sheds light on gene regulation mechanisms